Everything still feels so surreal. 🥲 Thank you to my parents, mentors, teachers, and friends for supporting me in every step of this journey. It truly takes a village, and I couldn't have done it without mine 💛 Excited for the next chapter!
With love,
Frances Ho, M.D.
In our recent @JAMAOnc paper (🔗 https://t.co/fVaKc3WtsL), we found using global data from @WHO@UNDP@IARCWHO@iaeaorg@WorldBank that GDP per capita and Universal Health Coverage Service coverage index were independently associated with cancer mortality-to-incidence ratio
1/ 📢 New publication in @JClinMed_MDPI!
We analyzed @IHME_UW GBD 2021 data to quantify 30 years of trends in heme cancers across six East Asian countries, revealing major shifts in incidence, mortality & overall cancer burden.
🔗 https://t.co/rpMkvNra1o
#mmsm#lymsm#leusm
We recommend:
🔄 continuous HF pathway implementation at @UPManilaOnline@UPPGHmedicine w/ periodic eval and stakeholder feedback
‼️ expanding in-hospital diagnostics and HR supply to meet ⬆️patient needs
🙏 Thank you to Dr Sabando, Dr Punzalan, and team for this opportunity!
📝 Our latest - from the @UPPGHmedicine HF study group 🫀
In our study of acute HF patients at our 🇵🇭 govt ER, we found:
⬇️ low adherence to ⬆️resource orders: q1 UO monitoring, hooking to 🫀 monitor, and timely ECG
⬆️ MDs over-order Trop I, Ca, Mg, Alb
https://t.co/VPD6XbWgv9
Recent cuts to global health care funding could put lifesaving health care at risk for the world’s most vulnerable. IHME’s Financing Global Health (FGH) 2025 report includes most up-to-date estimates of development assistance for health (DAH): https://t.co/v2nn34mpfj
The growing cancer burden may be met by efforts to strengthen the clinical workforce, improve gender equity, increase healthcare resource allocation, and promote universal healthcare coverage. https://t.co/OJg2mdasOA @EChrisDee@erin_feliciano@iyengarpuneeth
"In a political climate where funding for cancer research is under threat & access to healthcare for minority communities faces increasing barriers, [we need] cost-effective, preventative interventions with a higher return on the investment in terms of public health"
Editorial 👇
Some of the best parts of #ASCO25 is the opportunity to meet in person your research collaborators from around the world!!
Check one of our groups’ most recent publications on “National Cancer System Characteristics and Global Pan-Cancer Outcomes: https://t.co/1jbecD0JUb
🚨Proud to share our latest publication in @EurUrolOncol:
The burden of genitourinary cancers in Southeast Asia has risen significantly from 1990–2021. Findings highlight the urgent need for equitable access to cancer care in the region.
🔗 https://t.co/Ff5N4P61bC
Excited to share our review article on SLE care in the Philippines! 🇵🇭
Thank you to our senior and consultant authors, @drdrlads @doktora_ging for the guidance.
And to the rest of our co-authors as well: @_quenphilip@francesvho et al.
READ: https://t.co/tPVPF5AkMR
#med
Led by @EChrisDee, we explored determinants of #global#cancer outcomes in @JAMAOnc 🌎🌍🌏
We need to ⬆️ the clinical workforce, ⬆️ #genderequity, ⬆️ health care resource allocation & ⬆️ #universalhealthcare coverage!
More to come from our global team!
https://t.co/1jbecD0c4D